Am J Epidemiol 2002; 156:158-164.
Copyright © 2002 by the
Johns Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Human Papillomavirus and the Long-term Risk of Cervical Neoplasia
1 Julius Center for General Practice and Patient Oriented Research, University Medical Center Utrecht, Utrecht, the Netherlands.
2 Delft Diagnostic Laboratory, Delft, the Netherlands.
3 Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherland.
The risk of cervical neoplasia for women with normal Papanicolaou smears was calculated for those whose smears were human papillomavirus (HPV) positive and those whose smears were HPV negative. Data on 347 cases and controls were analyzed in a population-based, nested case-control study. Cases (n = 77) were women who participated in the Utrecht screening program (1976–1984) in the Netherlands and who developed cervical intraepithelial neoplasia 3 or microinvasive or invasive squamous cervical cancer after having a negative smear (1980–1986). Controls (n = 270) were matched on age (±5 years) and follow-up period. DNA was isolated from the Papanicolaou smears and was tested for the presence of HPV DNA by using the ultrasensitive broad-spectrum, general short-fragment polymerase chain reaction. HPV was found in 55 (71%) of the baseline smears of the 77 cases and in 31 (11%) of those of the 270 controls. The age-adjusted odds ratios for developing cervical intraepithelial neoplasia or microinvasive or invasive cervical cancer were 19.2 (95 percent confidence interval (CI): 10.3, 35.7) for HPV positivity in general, 5.4 (95% CI: 1.5, 19.5) for infection with low-risk HPV genotypes, 24.0 (95% CI: 12.4, 46.4) for high-risk HPV genotypes, and 104.8 (95% CI: 29.5, 372.7) for HPV type 16. Am J Epidemiol 2002;156:158–64.
cervix neoplasms; papillomavirus, human; vaginal smears
Abbreviations: Abbreviations: CI, confidence interval; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; PCR, polymerase chain reaction; Pap, Papanicolaou.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Sabol, M. Salakova, J. Smahelova, M. Pawlita, M. Schmitt, N. M. Gasperov, M. Grce, and R. Tachezy Evaluation of Different Techniques for Identification of Human Papillomavirus Types of Low Prevalence J. Clin. Microbiol., May 1, 2008; 46(5): 1606 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Bulk, L Rozendaal, G D Zielinski, J Berkhof, N C F. Daalmeijer, P J F Snijders, F J van Kemenade, and C J L M Meijer High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of "normal" smears preceding CIN2/3 J. Clin. Pathol., March 1, 2008; 61(3): 385 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Trottier, S. Mahmud, M. C. Costa, J. P. Sobrinho, E. Duarte-Franco, T. E. Rohan, A. Ferenczy, L. L. Villa, and E. L. Franco Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1274 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. M. Smits, R. Bakker, E. Jong, J. W. Mulder, P. L. Meenhorst, B. Kleter, L.-J. van Doorn, and W. G. V. Quint High Prevalence of Human Papillomavirus Infections in Urine Samples from Human Immunodeficiency Virus-Infected Men J. Clin. Microbiol., December 1, 2005; 43(12): 5936 - 5939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Rousseau, M. Abrahamowicz, L. L. Villa, M. C. Costa, T. E. Rohan, and E. L. Franco Predictors of Cervical Coinfection with Multiple Human Papillomavirus Types Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1029 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02) Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1. [Full Text] [PDF]
|
|
|
|
 |
|
 HPV Effects on Long-Term Risks of Cervical Cancer Journal Watch Infectious Diseases, August 9, 2002; 2002(809): 5 - 5. [Full Text]
|
|